What You Should Know:
– Thoma Bravo, a private equity software investment firm has acquired NextGen Healthcare, Inc, for over $1.8B in cash.
– Under the terms of the agreement, NextGen Healthcare shareholders will receive $23.95…
Continue Reading
After more than four decades as a publicly traded health IT company, NextGen Healthcare will be taken private by Thoma Bravo in an acquisition valued at $1.8 billion, it was announced on Wednesday.WHY IT MATTERS
NextGen, which…
Kuldeep Singh Rajput
What You Should Know:
– Biofourmis founder and CEO Kuldeep Singh Rajput has quietly resigned as CEO, according to the company’s spokesperson. The company has appointed private equity investor General Altantic’s Ben Wanamaker…
Continue Reading
What You Should Know:
Private equity investment firm Cressey & Company LP (“Cressey”) acquires HealthDrive, a leading multi-specialty clinical services organization to patients residing in long-term care facilities, from Bain Capital Double Impact.The investment will…
Continue Reading
Top News
Roper Technologies acquires enterprise performance management software vendor Syntellis from its private equity owners for $1.4 billion in cash.
Roper will combine the acquired company with its Strata Decision Technology business.
Syntellis was…
TPG, a global alternative asset management firm, announced today that it has signed a definitive agreement to acquire Nextech, a leading provider of clinical and administrative healthcare technology solutions for specialty physician practices, from…
Continue Reading
Top News
A ransomware attack on Prospect Medical Holdings disrupts or shuts down its 16 hospitals and 165 outpatient locations across five states.
The company’s hospitals are in Southern California, Connecticut, Pennsylvania, and Rhode Island. They…
Top News
Private equity firm Thomas H. Lee Partners sells specialty EHR/PM vendor Nextech to another PE firm, TPG, for $1.4 billion.
THL bought the company for $500 million in June 2019, after which it…
The healthcare industry faced several headwinds in the last year, such as higher interest rates, more antitrust regulatory review concerns, higher valuations and recession worries. But despite these headwinds, health services deals “remained resilient”…
Continue Reading
The healthcare and life sciences industries have entered new stages in their growth fueled by private equity (PE) investment acquisition. The pace of new platform formation and consolidation has begun to see the increase…
Continue Reading
